<?xml version='1.0' encoding='utf-8'?>
<document id="26224203"><sentence text="Drug-metabolism mechanism: Knowledge-based population pharmacokinetic approach for characterizing clobazam drug-drug interactions."><entity charOffset="98-106" id="DDI-PubMed.26224203.s1.e0" text="clobazam" /></sentence><sentence text="A metabolic mechanism-based characterization of antiepileptic drug-drug interactions (DDIs) with clobazam in patients with Lennox-Gastaut syndrome (LGS) was performed using a population pharmacokinetic (PPK) approach" /><sentence text=" To characterize potential DDIs with clobazam, pharmacokinetic (PK) data from 153 patients with LGS in study OV-1012 (NCT00518713) and 18 healthy participants in bioavailability study OV-1017 were pooled" /><sentence text=" Antiepileptic drugs (AEDs) were grouped based on their effects on the cytochrome P450 (CYP) isozymes responsible for the metabolism of clobazam and its metabolite, N-desmethylclobazam (N-CLB): CYP3A inducers (phenobarbital, phenytoin, and carbamazepine), CYP2C19 inducers (valproic acid, phenobarbital, phenytoin, and carbamazepine), or CYP2C19 inhibitors (felbamate, oxcarbazepine)"><entity charOffset="165-184" id="DDI-PubMed.26224203.s4.e0" text="N-desmethylclobazam" /><entity charOffset="186-191" id="DDI-PubMed.26224203.s4.e1" text="N-CLB" /><entity charOffset="210-223" id="DDI-PubMed.26224203.s4.e2" text="phenobarbital" /><entity charOffset="225-234" id="DDI-PubMed.26224203.s4.e3" text="phenytoin" /><entity charOffset="240-253" id="DDI-PubMed.26224203.s4.e4" text="carbamazepine" /><entity charOffset="256-263" id="DDI-PubMed.26224203.s4.e5" text="CYP2C19" /><entity charOffset="274-287" id="DDI-PubMed.26224203.s4.e6" text="valproic acid" /><entity charOffset="289-302" id="DDI-PubMed.26224203.s4.e7" text="phenobarbital" /><entity charOffset="304-313" id="DDI-PubMed.26224203.s4.e8" text="phenytoin" /><entity charOffset="319-332" id="DDI-PubMed.26224203.s4.e9" text="carbamazepine" /><entity charOffset="358-367" id="DDI-PubMed.26224203.s4.e10" text="felbamate" /><entity charOffset="369-382" id="DDI-PubMed.26224203.s4.e11" text="oxcarbazepine" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e0" e2="DDI-PubMed.26224203.s4.e0" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e0" e2="DDI-PubMed.26224203.s4.e1" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e0" e2="DDI-PubMed.26224203.s4.e2" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e0" e2="DDI-PubMed.26224203.s4.e3" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e0" e2="DDI-PubMed.26224203.s4.e4" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e0" e2="DDI-PubMed.26224203.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e0" e2="DDI-PubMed.26224203.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e0" e2="DDI-PubMed.26224203.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e0" e2="DDI-PubMed.26224203.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e0" e2="DDI-PubMed.26224203.s4.e9" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e0" e2="DDI-PubMed.26224203.s4.e10" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e0" e2="DDI-PubMed.26224203.s4.e11" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e1" e2="DDI-PubMed.26224203.s4.e1" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e1" e2="DDI-PubMed.26224203.s4.e2" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e1" e2="DDI-PubMed.26224203.s4.e3" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e1" e2="DDI-PubMed.26224203.s4.e4" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e1" e2="DDI-PubMed.26224203.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e1" e2="DDI-PubMed.26224203.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e1" e2="DDI-PubMed.26224203.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e1" e2="DDI-PubMed.26224203.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e1" e2="DDI-PubMed.26224203.s4.e9" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e1" e2="DDI-PubMed.26224203.s4.e10" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e1" e2="DDI-PubMed.26224203.s4.e11" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e2" e2="DDI-PubMed.26224203.s4.e2" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e2" e2="DDI-PubMed.26224203.s4.e3" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e2" e2="DDI-PubMed.26224203.s4.e4" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e2" e2="DDI-PubMed.26224203.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e2" e2="DDI-PubMed.26224203.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e2" e2="DDI-PubMed.26224203.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e2" e2="DDI-PubMed.26224203.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e2" e2="DDI-PubMed.26224203.s4.e9" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e2" e2="DDI-PubMed.26224203.s4.e10" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e2" e2="DDI-PubMed.26224203.s4.e11" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e3" e2="DDI-PubMed.26224203.s4.e3" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e3" e2="DDI-PubMed.26224203.s4.e4" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e3" e2="DDI-PubMed.26224203.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e3" e2="DDI-PubMed.26224203.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e3" e2="DDI-PubMed.26224203.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e3" e2="DDI-PubMed.26224203.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e3" e2="DDI-PubMed.26224203.s4.e9" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e3" e2="DDI-PubMed.26224203.s4.e10" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e3" e2="DDI-PubMed.26224203.s4.e11" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e4" e2="DDI-PubMed.26224203.s4.e4" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e4" e2="DDI-PubMed.26224203.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e4" e2="DDI-PubMed.26224203.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e4" e2="DDI-PubMed.26224203.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e4" e2="DDI-PubMed.26224203.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e4" e2="DDI-PubMed.26224203.s4.e9" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e4" e2="DDI-PubMed.26224203.s4.e10" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e4" e2="DDI-PubMed.26224203.s4.e11" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e5" e2="DDI-PubMed.26224203.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e5" e2="DDI-PubMed.26224203.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e5" e2="DDI-PubMed.26224203.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e5" e2="DDI-PubMed.26224203.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e5" e2="DDI-PubMed.26224203.s4.e9" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e5" e2="DDI-PubMed.26224203.s4.e10" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e5" e2="DDI-PubMed.26224203.s4.e11" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e6" e2="DDI-PubMed.26224203.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e6" e2="DDI-PubMed.26224203.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e6" e2="DDI-PubMed.26224203.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e6" e2="DDI-PubMed.26224203.s4.e9" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e6" e2="DDI-PubMed.26224203.s4.e10" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e6" e2="DDI-PubMed.26224203.s4.e11" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e7" e2="DDI-PubMed.26224203.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e7" e2="DDI-PubMed.26224203.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e7" e2="DDI-PubMed.26224203.s4.e9" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e7" e2="DDI-PubMed.26224203.s4.e10" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e7" e2="DDI-PubMed.26224203.s4.e11" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e8" e2="DDI-PubMed.26224203.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e8" e2="DDI-PubMed.26224203.s4.e9" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e8" e2="DDI-PubMed.26224203.s4.e10" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e8" e2="DDI-PubMed.26224203.s4.e11" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e9" e2="DDI-PubMed.26224203.s4.e9" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e9" e2="DDI-PubMed.26224203.s4.e10" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e9" e2="DDI-PubMed.26224203.s4.e11" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e10" e2="DDI-PubMed.26224203.s4.e10" /><pair ddi="false" e1="DDI-PubMed.26224203.s4.e10" e2="DDI-PubMed.26224203.s4.e11" /></sentence><sentence text=" CYP3A4 inducers-which did not affect the oral clearance of clobazam-significantly increased the formation of N-CLB by 9"><entity charOffset="110-115" id="DDI-PubMed.26224203.s5.e0" text="N-CLB" /></sentence><sentence text="4%, while CYP2C19 inducers significantly increased the apparent elimination rate of N-CLB by 10"><entity charOffset="84-89" id="DDI-PubMed.26224203.s6.e0" text="N-CLB" /></sentence><sentence text="5%, resulting in a negligible net change in the PK of the active metabolite" /><sentence text=" CYP2C19 inhibitors did not affect N-CLB elimination"><entity charOffset="35-39" id="DDI-PubMed.26224203.s8.e0" text="N-CLB" /></sentence><sentence text=" Because concomitant use of AEDs that are either CYP450 inhibitors or inducers with clobazam in the treatment of LGS patients had negligible to no effect on clobazam PK in this study, dosage adjustments may not be required for clobazam in the presence of the AEDs investigated here"><entity charOffset="84-92" id="DDI-PubMed.26224203.s9.e0" text="clobazam" /><entity charOffset="227-235" id="DDI-PubMed.26224203.s9.e1" text="clobazam" /><pair ddi="false" e1="DDI-PubMed.26224203.s9.e0" e2="DDI-PubMed.26224203.s9.e0" /><pair ddi="false" e1="DDI-PubMed.26224203.s9.e0" e2="DDI-PubMed.26224203.s9.e1" /></sentence><sentence text=" " /></document>